Models for Prediction of Factor VIII Half-Life in Severe Haemophiliacs: Distinct Approaches for Blood Group O and Non-O Patients

PLoS ONE - United States
doi 10.1371/journal.pone.0006745
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Blood Group Types O and Non-O Are Associated With Coronary Collateral Circulation Development

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2020English

Successful Haemostasis With Extended Half-Life Recombinant Factor VIII in Circumcision

Turkish Journal of Haematology
Hematology
2019English

Real-World Health Care Expenditure in Hemophilia a Patients Using Standard and Extended Half-Life Recombinant Factor VIII Products

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Anti-A Haemolysin in Group O Blood Donors

BMJ
1959English

Psy65 - Real-World Data Analysis of Us Claims Data on Coagulation Factor Ix Dispensation and Expenditures in Patients With Severe Hemophilia B: Standard Half-Life vs. Extended Half-Life Products

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Factor VIII and IX Assays for Post-Infusion Monitoring in Hemophilia Patients: Guidelines From the French BIMHO Group (GFHT)

European Journal of Haematology
MedicineHematology
2020English

Non-A Non-B Hepatitis After Transfusion of Factor VIII in Infrequently Treated Patients.

BMJ
1983English

3- O Sulfation of Heparin Leads to Hepatotropism and Longer Circulatory Half-Life

Thrombosis Research
Hematology
2018English

Reduced Prevalence of Placental Malaria in Primiparae With Blood Group O

Malaria Journal
ParasitologyInfectious Diseases
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy